LLLaura M. Langan

Laura M. Langan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura M. Langan has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Environmentally Safe and Just Pharmacy: A Framework and Action Plan for Operating within the Earth System Boundary for Novel Entities

    by Alistair B. A. Boxall, Priyanie Amerasinghe, Sally Beckenham, Michael G. Bertram, Sally Gaw, Austin D. Gray, Karen A. Kidd, Laura M. Langan, Kenneth M. Y. Leung, Jack L. Manera, et al.

    Active pharmaceutical ingredients (APIs) are essential for global health, yet their use and release into the environment contribute to the transgression of the Earth System Boundary for Novel Entities. This study proposes a novel framework for an Environmentally Safe and Just Pharmacy, establishing 4 overarching criteria and 12 subcriteria designed to ensure that the pharmaceutical lifecycle is environmentally safe and just from a novel entities perspective. Using the extensive expertise of our global author group, we conclude that current practices for API design and development, approval and monitoring, use and disposal are only partially or poorly aligned with our criteria. Key vulnerabilities include a lack of environmental considerations in early-stage drug design, widespread exceedances of environmental concentrations deemed safe to ecosystems, persistent selection for antimicrobial resistance in the environment, and severe data gaps in low- and middle-income countries. We further highlight environmental injustices, particularly for Indigenous and marginalized communities whose cultural identities and livelihoods are compromised by chemical contamination. To address these challenges, we present a 10-point roadmap for a transition to a sustainable future by 2050. This plan includes calls for green chemistry investments, the integration of social and cultural equity into risk assessments, and the global upgrade of treatment and management infrastructure. We emphasize that solutions to pharmaceutical impacts must be culturally sensitive and safeguard the dignity of vulnerable populations to ensure a truly just transition that operates within Earth System Boundaries.


  • Open Access

    Spatially Informed Wastewater Differentiation among Locations during an Ongoing Measles Outbreak in Texas, USA

    by Laura M. Langan, Fallon L. Bain, Christine C. Snow, Janelle Oldfather, Olivia Sagvold, Kacie Kaneshiro, Charlotte Nwagwu, HyeongYoung Choi, Adam R. Wronski, Alamin, et al.

    Though reverse transcription-quantitative polymerase chain reaction (RT-qPCR), RT digital PCR (RT-dPCR), and RT digital droplet PCR (RT-ddPCR) are commonly used for wastewater-based epidemiology and surveillance (WBE/WBS), differences among the platforms exist. While RT-ddPCR has been suggested as an ideal approach to use globally for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monitoring, access to RT-qPCR instrumentation is more widely available in many regions, and it is more economical. Subsequently, a larger number of studies have used RT-qPCR for SARS-CoV-2 wastewater monitoring, along with additional pathogens that can be detected with WBS. In this study, we employed RT-qPCR and RT-dPCR platforms for the comparative detection of vaccine (A genotype Edmonston) and wild-type (D8 genotype) measles RNA from wastewater in nearby cities separated by <50 km during an ongoing measles outbreak in Texas, USA, in addition to several other locations up to 30-1400 km from the outbreak location. The limit of detection (LOD) for each methodology was evaluated using a synthetic gBlock DNA gene fragment of known concentrations, with comparable LODs identified for both the RT-dPCR (∼0.5 gc/μL) and RT-qPCR (∼0.4 gc/μL) platforms. Using composite supernatant-solid wastewater samples, RNA aliquots were analyzed on each platform in parallel. The RT-qPCR platform demonstrated a higher detection rate than RT-dPCR for the vaccine strain quantified in wastewater samples, with equivalent detections for the wild-type strain in both platforms, and notable differences in the gene copies quantified in wastewater based on the platform. Our study identifies that regardless of PCR methodology employed, WBS is a particularly valuable approach for the spatially informed differentiation of measles during rapid response to an active outbreak.


  • Inhibition of Fin Regeneration in Fathead Minnow (Pimephales promelas) by a Potent Synthetic Glucocorticoid and Development of Adverse Outcome Pathway 334

    by Alexander R. Cole, Gerald T. Ankley, Jenna E. Cavallin, Jacob R. Collins, Kathleen M. Jensen, Michael D. Kahl, Alex J. Kasparek, Ba Reum Kwon, Yesmeena M. Shmaitelly, Laura M. Langan, et al.

    Despite structural and functional conservation across vertebrate species, the glucocorticoid receptor has been minimally studied in comparison to other biological targets for endocrine-disrupting compounds in aquatic systems. Because prolonged use of pharmaceutical glucocorticoids in humans has been linked to osteoporosis and impaired bone growth, we hypothesized that the ability of teleost fish to regenerate fins following damage may be inhibited by exposure to synthetic glucocorticoids in the environment. In the present study, we examined fin regeneration following a 7 days waterborne exposure of juvenile fathead minnows (Pimephales promelas) to the synthetic glucocorticoids, fluticasone propionate and dexamethasone. Expression of several biologically relevant gene products (sgk1, tdgf1, runx2a, lef1, shha, and tsc22d3) was measured in paired caudal fin and whole-body tissues. Fluticasone propionate and dexamethasone significantly impaired fin regeneration at measured water concentrations of 2.62 μg/L and 4.62 mg/L, respectively. Changes in gene expression indicated disruption of intercellular communication in the Wnt/β-catenin and bone morphogenetic protein (BMP) signaling pathways after exposure to 4.86 μg/L fluticasone propionate. Upregulation of tsc22d3, a transcription factor responsible for suppression of anti-inflammatory response, may be the plausible cause of repressed cellular signaling. These findings advance the development of adverse outcome pathway 334─Glucocorticoid Receptor Activation Leads to Impaired Fin Regeneration─and elucidate both the mechanistic relationship between activation of the glucocorticoid receptor by fluticasone propionate and inhibition of fin regeneration, which could plausibly reduce individual fitness in aquatic systems.


  • Discharge of Per- and Polyfluoroalkyl Substances in Reclaimed Wastewater: Temporal Water Quality Implications for Effluent-Dominated Systems

    by Kevin M. Stroski, Jaylen L. Sims, Adam R. Wronski, Fallon L. Bain, Christine C. Snow, Abigail N. Henke, Laura M. Langan, Bryan W. Brooks


  • Open Access

    Experimental reporting of fish transcriptomic responses in environmental toxicology and ecotoxicology

    by Laura M Langan, Camille G Baettig, Alexander R Cole, Lea Lovin, Kendall Scarlett, Adam R Wronski, Megan E O’bRien, Yesmeena Shmaitelly, Bryan W Brooks

    Due to its increasing affordability and efforts to understand transcriptional responses of organisms to biotic and abiotic stimuli, transcriptomics has become an important tool with significant impact on toxicological investigations and hazard and risk assessments, especially during development and application of new approach methodologies (NAMs). Data generated using transcriptomic methodologies have directly informed adverse outcome pathway frameworks, chemical and biological read across, and aided in the identification of points of departure. Using data reporting frameworks for transcriptomics data offers improved transparency and reproducibility of research and an opportunity to identify barriers to adoption of these NAMs, especially in environmental toxicology and ecotoxicology with aquatic models. Improved reporting also allows for reexamination of existing data, limiting needs for experiment replication and further reducing animal experimentation. Here, we use a standardized form of data reporting for omics-based studies, the Organisation for Economic Co-operation and Development omics reporting framework, which specifically reports on a list of parameters that should be included in transcriptomics studies used in a regulatory context. We focused specifically on fish studies using RNA- Sequencing (Seq)/microarray technologies within a toxicology context. Inconsistencies in reporting and methodologies among the experimental designs (toxicology vs. molecular characterization) were observed in addition to foundational differences in reporting of sample concentration or preparation or quality assessments, which can affect reproducibility and read across, confidence in results, and contribute substantially to understanding molecular mechanisms of toxicants and toxins. Our findings present an opportunity for improved research reporting. We also provide several recommendations as logical steps to reduce barriers to adoption of transcriptomics within environmental toxicology and ecotoxicology.


  • Open Access

    Comparative glucocorticoid receptor agonism: In silico, in vitro, and in vivo and identification of potential biomarkers for synthetic glucocorticoid exposure

    by Alexander R Cole, Brett R Blackwell, Jenna E Cavallin, Jacob E Collins, Ashley R Kittelson, Yesmeena M Shmaitelly, Laura M Langan, Daniel L Villeneuve, Bryan W Brooks

    The glucocorticoid receptor (GR) is present in almost every vertebrate cell and is utilized in many biological processes. Despite an abundance of mammalian data, the structural conservation of the receptor and cross-species susceptibility, particularly for aquatic species, has not been well defined. Efforts to reduce, refine and/or replace animal testing have increased, driving the impetus to advance development of New Approach Methodologies (NAMs). Here we employed in silico, in vitro and in vivo methods to elucidate a greater understanding of receptor-mediated effects of synthetic glucocorticoid exposure in teleost fish. Evolutionary conservation of amino acid residues critical for transcriptional activation was confirmed in silico using Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS). Subsequent in vitro assays using zebrafish and human GR provided evidence of physiological congruence of GR agonism. Finally, adult fathead minnows (Pimephales promelas) were exposed in vivo to the synthetic glucocorticoids, dexamethasone (0.04, 400, 4000 µg/L) and beclomethasone dipropionate (130 µg/L), and GR agonism confirmed via digital PCR; in addition, EcoToxChip analyses identified potential mRNA biomarkers following glucocorticoid exposure. These findings support the use of NAMs to potentially reduce multi-species in vivo experimentation, while providing empirical evidence that expands the taxonomic domain of applicability (tDOA) for the GR agonism molecular initiating event within the broader GR agonism adverse outcome pathway network.


  • Exploring animal methods bias in biomedical research funding: Workshop proceedings and action steps

    by Catharine E. Krebs, Sven Geissler, Kathrin Herrmann, Kenneth Kandaras, Owen Kavanagh, Laura M. Langan, Francesca Pistollato, Sandeep Raha, Ignacio J. Tripodi, Emily R. Trunnell


  • Open Access

    (+) Anatoxin-a elicits differential survival, photolocomotor behavior, and gene expression in two alternative vertebrate models

    by Lea M. Lovin, Laura M. Langan, Kendall R. Scarlett, Raegyn B. Taylor, Sujin Kim, C. Kevin Chambliss, Saurabh Chatterjee, J. Thad Scott, Bryan W. Brooks


  • Open Access

    Proteome changes in larval zebrafish (Danio rerio) and fathead minnow (Pimephales promelas) exposed to (±) anatoxin-a

    by Laura M. Langan, Lea M. Lovin, Raegyn B. Taylor, Kendall R. Scarlett, C. Kevin Chambliss, Saurabh Chatterjee, J. Thad Scott, Bryan W. Brooks